These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34738838)

  • 1. Diagnostic challenge of identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving
    Bendig S; Stengel A; Walter W; Meggendorfer M; Baer C; Müller ML; Haferlach T; Kern W; Haferlach C
    Leuk Lymphoma; 2022 Mar; 63(3):747-750. PubMed ID: 34738838
    [No Abstract]   [Full Text] [Related]  

  • 2. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid.
    Wang W; Beird H; Kroll CJ; Hu S; Bueso-Ramos CE; Fang H; Tang G; Tang Z; Wang F; Takahashi K; You MJ; Khoury JD; Medeiros LJ; Futreal PA
    Leukemia; 2020 Sep; 34(9):2509-2512. PubMed ID: 32099038
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.
    Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ
    Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene.
    Bezrookove V; van Zelderen-Bhola SL; Brink A; Szuhai K; Raap AK; Barge R; Beverstock GC; Rosenberg C
    Cancer Genet Cytogenet; 2004 Feb; 149(1):72-6. PubMed ID: 15104287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
    Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
    Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
    Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
    Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer Hijacking Drives Oncogenic
    Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
    Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
    MacLeod RA; Nagel S; Drexler HG
    Cancer Genet Cytogenet; 2004 Aug; 153(1):88-9. PubMed ID: 15325104
    [No Abstract]   [Full Text] [Related]  

  • 11. The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.
    Salaverria I; Akasaka T; Gesk S; Szczepanowski M; Burkhardt B; Harder L; Damm-Welk C; Oschlies I; Klapper W; Dyer MJ; Siebert R
    Genes Chromosomes Cancer; 2012 Apr; 51(4):338-43. PubMed ID: 22420028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Flow Cytometry for Mixed Phenotype and Ambiguous Leukemias.
    Kurzer JH; Weinberg OK
    Clin Lab Med; 2023 Sep; 43(3):399-410. PubMed ID: 37481319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24).
    Micci F; Thorsen J; Panagopoulos I; Nyquist KB; Zeller B; Tierens A; Heim S
    Leukemia; 2013 Apr; 27(4):980-2. PubMed ID: 23032695
    [No Abstract]   [Full Text] [Related]  

  • 14. Translocation t(1;16)(p31;q24) rearranging CBFA2T3 is specific for acute erythroid leukemia.
    Micci F; Thorsen J; Haugom L; Zeller B; Tierens A; Heim S
    Leukemia; 2011 Sep; 25(9):1510-2. PubMed ID: 21606959
    [No Abstract]   [Full Text] [Related]  

  • 15. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.
    Kuriakose P; Perveen N; Maeda K; Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):156-8. PubMed ID: 15066324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
    Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
    Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.
    Montefiori LE; Mullighan CG
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia.
    Chapiro E; Russell LJ; Struski S; Cavé H; Radford-Weiss I; Valle VD; Lachenaud J; Brousset P; Bernard OA; Harrison CJ; Nguyen-Khac F
    Leukemia; 2010 Jul; 24(7):1362-4. PubMed ID: 20485370
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2).
    Nagel S; Kaufmann M; Drexler HG; MacLeod RA
    Cancer Res; 2003 Sep; 63(17):5329-34. PubMed ID: 14500364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.